Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr541 Inhibitors

Olr541 inhibitors represent a specialized class of chemical compounds that interact with the Olr541 receptor, a type of G-protein-coupled receptor (GPCR) located primarily in olfactory tissues. The Olr541 receptor, encoded by the corresponding gene, is involved in the detection of specific odorant molecules, playing a role in the olfactory signaling pathway that enables the perception of smell. Olr541 inhibitors are typically small molecules or peptides designed to modulate the activity of this receptor by binding to its active site or allosteric sites, thereby altering its conformational state. This modulation can result in the suppression or enhancement of olfactory signal transduction depending on the nature of the inhibitor and its specific interaction with the receptor. The structural diversity of Olr541 inhibitors is a key aspect of their function, as slight variations in molecular geometry, charge distribution, and hydrophobicity can drastically influence their binding affinity and specificity.

In terms of molecular architecture, Olr541 inhibitors often possess a core scaffold that is optimized for receptor interaction, flanked by functional groups that enhance their selectivity and potency. The design of these inhibitors requires a deep understanding of the receptor's three-dimensional structure, often elucidated through techniques such as X-ray crystallography or cryo-electron microscopy. Computational modeling and molecular docking studies are frequently employed to predict the binding modes of potential inhibitors, guiding the synthesis of novel compounds. Additionally, these inhibitors may exhibit a range of physicochemical properties, including lipophilicity, solubility, and stability, all of which are critical for their activity and practical application in olfactory research. The development of Olr541 inhibitors not only advances the understanding of olfactory receptor function but also contributes to the broader field of chemical biology, where the modulation of GPCR activity is of significant interest.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tivozanib

475108-18-0sc-475339
5 mg
$320.00
(0)

VEGF receptor inhibitor, potentially affecting proteins involved in angiogenesis and tumor growth.

Regorafenib

755037-03-7sc-477163
sc-477163A
25 mg
50 mg
$320.00
$430.00
3
(0)

Multi-kinase inhibitor, potentially affecting proteins in angiogenesis, oncogenesis, and the tumor microenvironment.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

EGFR inhibitor, specifically targeting T790M mutation, potentially affecting proteins in mutated EGFR pathways.

Zanubrutinib

1691249-45-2sc-507434
5 mg
$360.00
(0)

Bruton's tyrosine kinase inhibitor, potentially affecting proteins in B-cell receptor signaling.

BAY 80-6946

1032568-63-0sc-503264
5 mg
$562.00
(0)

PI3K inhibitor, potentially altering proteins involved in cell signaling and survival pathways.

Encorafenib

1269440-17-6sc-507422
1 mg
$115.00
(0)

BRAF inhibitor, potentially affecting proteins involved in the MAPK/ERK pathway.

Lenvatinib

417716-92-8sc-488530
sc-488530A
sc-488530B
5 mg
25 mg
100 mg
$182.00
$661.00
$1690.00
3
(0)

Inhibits multiple tyrosine kinases, including VEGFR, potentially affecting angiogenesis-related proteins.

Ribociclib

1211441-98-3sc-507367
10 mg
$450.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

ALK inhibitor, potentially affecting proteins in ALK-driven signaling pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

PARP inhibitor, potentially affecting proteins involved in DNA repair pathways.